http://www.ptemag.com/pharmtecheurope/Latest+News/Article/list/45298 Latest pharmaceutical news 2010-09-06T19:04:33Z http://www.ptemag.com/pharmtecheurope/Latest+News/Six-step-plan-for-improved-FDA-enforcement/ArticleStandard/Article/detail/618345?contextCategoryId=45298&ref=25 FDA Commissioner Margaret Hamburg has outlined six initial steps designed to improve the effectiveness and timeliness of FDA?s regulatory and enforcement system. 2009-08-14T04:00:00Z http://www.ptemag.com/pharmtecheurope/data/articlestandard/pharmtecheurope/332009/618345null HTML http://www.ptemag.com/pharmtecheurope/Latest+News/Green-manufacturing-with-marine-microbes/ArticleStandard/Article/detail/617979?contextCategoryId=45298&ref=25 Manufacturing methods for new drugs could be made greener and more efficient with the help of marine microbes. 2009-08-14T04:00:00Z http://www.ptemag.com/pharmtecheurope/data/articlestandard/pharmtecheurope/332009/617979null HTML http://www.ptemag.com/pharmtecheurope/Latest+News/Step-carefully-into-foreign-affairs/ArticleStandard/Article/detail/617977?contextCategoryId=45298&ref=25 As the pharmaceutical industry looks to emerging markets, corruption becomes an important issue. 2009-08-14T04:00:00Z http://www.ptemag.com/pharmtecheurope/data/articlestandard/pharmtecheurope/332009/617977null HTML http://www.ptemag.com/pharmtecheurope/Latest+News/FDA-guidance-on-monitoring-at-risk-melamine-contam/ArticleStandard/Article/detail/618346?contextCategoryId=45298&ref=25 The FDA has released its Guidance for Industry titled Pharmaceutical Components at Risk for Melamine Contamination. 2009-08-14T04:00:00Z http://www.ptemag.com/pharmtecheurope/data/articlestandard/pharmtecheurope/332009/618346null HTML http://www.ptemag.com/pharmtecheurope/Latest+News/GSK-buys-rights-to-staph-infection-vaccine/ArticleStandard/Article/detail/617978?contextCategoryId=45298&ref=25 GlaxoSmithKline (GSK) has signed an agreement to acquire US-based Nabi Biopharmaceuticals' PentaStaph programme, which will provide the company with a five component vaccine candidate for Pentavalent S. aureus. 2009-08-14T04:00:00Z http://www.ptemag.com/pharmtecheurope/data/articlestandard/pharmtecheurope/332009/617978null HTML http://www.ptemag.com/pharmtecheurope/Latest+News/Antipsychotic-drugs-dominate/ArticleStandard/Article/detail/617975?contextCategoryId=45298&ref=25 There is a considerable commercial opportunity for developers of antipsychotic drugs, according to market analysts Datamonitor, which claims that this class of drugs dominates the US market and boasted a global value of approximately $22 billion in 2008. 2009-08-14T04:00:00Z http://www.ptemag.com/pharmtecheurope/data/articlestandard/pharmtecheurope/332009/617975null HTML http://www.ptemag.com/pharmtecheurope/Latest+News/BIO-asks-Supreme-Court-to-overturn-iBilskii/ArticleStandard/Article/detail/618347?contextCategoryId=45298&ref=25 The Biotechnology Industry Organization (BIO) has filed an amicus brief asking the US Supreme Court to overturn Bilski versus Doll, a decision of the US Court of Appeals for the Federal Circuit. 2009-08-13T04:00:00Z http://www.ptemag.com/pharmtecheurope/data/articlestandard/pharmtecheurope/332009/618347null HTML http://www.ptemag.com/pharmtecheurope/Latest+News/Freeze-drying-centre-of-excellence-unveiled/ArticleStandard/Article/detail/616344?contextCategoryId=45298&ref=25 Reig Jofre has revealed further details about its Barcelona (Spain) based Centre of Excellence in the Freeze Drying Process — a project that represents an investment of approximately 12 million euro. 2009-08-07T04:00:00Z http://www.ptemag.com/pharmtecheurope/data/articlestandard/pharmtecheurope/322009/616344null HTML http://www.ptemag.com/pharmtecheurope/Latest+News/Pfizer-Vs-Nigerias-Kano-State-case-comes-to-a-clos/ArticleStandard/Article/detail/616358?contextCategoryId=45298&ref=25 An agreement has been reached between Pfizer and Nigeria's Kano State government following the long-running Trovan trial, which stems from the accusation that Pfizer illegally tested the antibiotic Trovan (trovafloxacin) on children in 1996 during a meningitis outbreak. 2009-08-07T04:00:00Z http://www.ptemag.com/pharmtecheurope/data/articlestandard/pharmtecheurope/322009/616358null HTML http://www.ptemag.com/pharmtecheurope/Latest+News/EMEA-and-FDA-collaborate-on-good-clinical-practice/ArticleStandard/Article/detail/616339?contextCategoryId=45298&ref=25 A joint initiative to collaborate on international Good Clinical Practice (GCP) inspection activities has been launched by the EMEA and the FDA. 2009-08-06T04:00:00Z http://www.ptemag.com/pharmtecheurope/data/articlestandard/pharmtecheurope/322009/616339null HTML http://www.ptemag.com/pharmtecheurope/Latest+News/String-of-attacks-aimed-at-Novartis-CEO/ArticleStandard/Article/detail/616573?contextCategoryId=45298&ref=25 Novartis has confirmed that the ashes of CEO Daniel Vasella?s mother have been stolen and his holiday home set fire to. 2009-08-06T04:00:00Z http://www.ptemag.com/pharmtecheurope/data/articlestandard/pharmtecheurope/322009/616573null HTML http://www.ptemag.com/pharmtecheurope/Latest+News/Cash-boost-for-projects-to-replace-reduce-and-refi/ArticleStandard/Article/detail/616343?contextCategoryId=45298&ref=25 Thirteen novel projects that aim to replace, reduce or refine animal testing have received funding totaling £4.5 million (approximately 5.3 million euro) from the UK's National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs). 2009-08-06T04:00:00Z http://www.ptemag.com/pharmtecheurope/data/articlestandard/pharmtecheurope/322009/616343null HTML http://www.ptemag.com/pharmtecheurope/Latest+News/EU-issues-study-on-REACH-implementation/ArticleStandard/Article/detail/616571?contextCategoryId=45298&ref=25 The Society of Chemical Manufacturers and Affiliates (SOCMA) has reported that Eurostat, the Statistical Office of the European Communities, has published a baseline study or the first snapshot of REACH policy in the preregistration phase. 2009-08-06T04:00:00Z http://www.ptemag.com/pharmtecheurope/data/articlestandard/pharmtecheurope/322009/616571null HTML http://www.ptemag.com/pharmtecheurope/Latest+News/APIs-delivered-by-sticky-webs/ArticleStandard/Article/detail/614718?contextCategoryId=45298&ref=25 GlaxoSmithKline (GSK) has granted 42 Technology worldwide pharmaceutical rights to a new precision powder dispensing technology that can quickly print powdered APIs onto edible or inert webs coated with adhesive to create a novel dose form. 2009-07-31T04:00:00Z http://www.ptemag.com/pharmtecheurope/data/articlestandard/pharmtecheurope/312009/614718null HTML http://www.ptemag.com/pharmtecheurope/Latest+News/Personalized-medicine-drives-MampAs/ArticleStandard/Article/detail/614716?contextCategoryId=45298&ref=25 The number of alliances between diagnostics and pharmaceutical companies is set to rise because of the growth of personalized medicine, according to a report from PricewaterhouseCoopers. 2009-07-31T04:00:00Z http://www.ptemag.com/pharmtecheurope/data/articlestandard/pharmtecheurope/312009/614716null HTML http://www.ptemag.com/pharmtecheurope/Latest+News/BMS-To-Acquire-Medarex/ArticleStandard/Article/detail/614724?contextCategoryId=45298&ref=25 In a move to strengthen development of its biologics portfolio, Bristol-Myers Squibb (BMS) has agreed to acquire the biopharmaceutical company Medarex (NJ, USA) for approximately $2.4 billion. 2009-07-31T04:00:00Z http://www.ptemag.com/pharmtecheurope/data/articlestandard/pharmtecheurope/312009/614724null HTML http://www.ptemag.com/pharmtecheurope/Latest+News/New-life-pumped-into-UK-pharma/ArticleStandard/Article/detail/614717?contextCategoryId=45298&ref=25 The UK's pharma sector will soon receive its own body to help employers drive the key skills agenda of the industry. 2009-07-31T04:00:00Z http://www.ptemag.com/pharmtecheurope/data/articlestandard/pharmtecheurope/312009/614717null HTML http://www.ptemag.com/pharmtecheurope/Latest+News/Transgenic-rats-provide-new-models-of-human-diseas/ArticleStandard/Article/detail/614719?contextCategoryId=45298&ref=25 Transgenic rats, created using a novel application of zinc finger nuclease (ZFN) technology, could aid the development of animal models of human diseases. 2009-07-30T04:00:00Z http://www.ptemag.com/pharmtecheurope/data/articlestandard/pharmtecheurope/312009/614719null HTML http://www.ptemag.com/pharmtecheurope/Latest+News/Extending-antibody-shelf-life/ArticleStandard/Article/detail/614723?contextCategoryId=45298&ref=25 Researchers working on extending the shelf life of antibody drugs may find help in a computer model developed by a research team at MIT (MA, USA). 2009-07-30T04:00:00Z http://www.ptemag.com/pharmtecheurope/data/articlestandard/pharmtecheurope/312009/614723null HTML http://www.ptemag.com/pharmtecheurope/Latest+News/Sanofi-Pasteur-boosts-vaccine-portfolio/ArticleStandard/Article/detail/614722?contextCategoryId=45298&ref=25 Sanofi aventis's vaccines division, Sanofi Pasteur (France), has acquired the ShanH subsidiary of Mërieux Alliance, which will give Sanofi Pasteur a majority stake in the Indian based vaccine producer Shantha Biotechnics. 2009-07-30T04:00:00Z http://www.ptemag.com/pharmtecheurope/data/articlestandard/pharmtecheurope/312009/614722null HTML http://www.ptemag.com/pharmtecheurope/Latest+News/Flu-vaccines-fast-tracked-in-the-EU/ArticleStandard/Article/detail/614715?contextCategoryId=45298&ref=25 The EMEA is racing to fast track the review of data on H1N1 pandemic vaccines before the start of the Northern hemisphere flu season, which is expected to begin in September. 2009-07-30T04:00:00Z http://www.ptemag.com/pharmtecheurope/data/articlestandard/pharmtecheurope/312009/614715null HTML http://www.ptemag.com/pharmtecheurope/Latest+News/Collaboration-to-tackle-asthma/ArticleStandard/Article/detail/612575?contextCategoryId=45298&ref=25 A new collaboration in the UK has been established to identify treatments that will stop asthma from worsening rather than simply alleviating the symptoms. 2009-07-24T04:00:00Z http://www.ptemag.com/pharmtecheurope/data/articlestandard/pharmtecheurope/302009/612575null HTML http://www.ptemag.com/pharmtecheurope/Latest+News/118-rise-in-medicines-detained-by-EU-customs/ArticleStandard/Article/detail/612576?contextCategoryId=45298&ref=25 Statistics published by the European Commission show a 118% increase in the number of medicines detained by EU customs in 2008 compared with 2007. 2009-07-24T04:00:00Z http://www.ptemag.com/pharmtecheurope/data/articlestandard/pharmtecheurope/302009/612576null HTML http://www.ptemag.com/pharmtecheurope/Latest+News/US-API-manufacturing-facility-to-be-dedicated/ArticleStandard/Article/detail/612579?contextCategoryId=45298&ref=25 A new, large-scale manufacturing facility offering western-based API supply will be dedicated on 30 July 2009 in Germantown (WI, USA) by Cambridge Major Laboratories. 2009-07-24T04:00:00Z http://www.ptemag.com/pharmtecheurope/data/articlestandard/pharmtecheurope/302009/612579null HTML http://www.ptemag.com/pharmtecheurope/Latest+News/Final-guidance-given-on-listing-drug-substance-imp/ArticleStandard/Article/detail/612911?contextCategoryId=45298&ref=25 The FDA has posted the final version of its Guidance for Industry, ANDAs: Impurities in Drug Substances. 2009-07-24T04:00:00Z http://www.ptemag.com/pharmtecheurope/data/articlestandard/pharmtecheurope/302009/612911null HTML http://www.ptemag.com/pharmtecheurope/Latest+News/Microneedles-moving-into-the-market/ArticleStandard/Article/detail/612574?contextCategoryId=45298&ref=25 Microneedle technology is moving closer to commercialization, according to research by Greystone Associates, as devices are being investigated by several companies lured by the potential advantages of extending the reach of transdermal drug delivery and the ability to meet the trend towards self administration. 2009-07-22T04:00:00Z http://www.ptemag.com/pharmtecheurope/data/articlestandard/pharmtecheurope/302009/612574null HTML http://www.ptemag.com/pharmtecheurope/Latest+News/EC-approves-Pfizers-Wyeth-take-over/ArticleStandard/Article/detail/612471?contextCategoryId=45298&ref=25 Pfizer's proposed acquisition of Wyeth appears to be on track after the European Commission (EC) issued its thumbs up under the EU's Merger Regulation; however, the approval came with a price as Pfizer has been told to divest several types of animal operations in the European Economic Area. 2009-07-21T04:00:00Z http://www.ptemag.com/pharmtecheurope/data/articlestandard/pharmtecheurope/302009/612471null HTML http://www.ptemag.com/pharmtecheurope/Latest+News/FDAs-Dr-Srinivasan-discusses-question-based-review/ArticleStandard/Article/detail/612910?contextCategoryId=45298&ref=25 Dr Aloka Srinivasan of the FDA's Office of Generic Drugs speaks about question-based reviews for generic drugs. 2009-07-20T04:00:00Z http://www.ptemag.com/pharmtecheurope/data/articlestandard/pharmtecheurope/302009/612910null HTML http://www.ptemag.com/pharmtecheurope/Latest+News/European-Pharmacopoeia-Commission-announces-new-st/ArticleStandard/Article/detail/610154?contextCategoryId=45298&ref=25 The European Pharmacopoeia Commission, which will celebrate its 60th anniversary this year, has announced progress towards international harmonization, as well as other ongoing activities, at the 134th session of the European Pharmacopoeia in France. 2009-07-17T04:00:00Z http://www.ptemag.com/pharmtecheurope/data/articlestandard/pharmtecheurope/282009/610154null HTML http://www.ptemag.com/pharmtecheurope/Latest+News/All-aboard-the-Twitter-bandwagon/ArticleStandard/Article/detail/610859?contextCategoryId=45298&ref=25 Resistance to the social networking revolution has been particularly high amongst pharmaceutical industry professionals, though now it seems that more and more are coming round to the idea. Interestingly, it?s not only the pharma elite that are jumping on the bandwagon; so too are government agencies and, most notably, the FDA. 2009-07-17T04:00:00Z http://www.ptemag.com/pharmtecheurope/data/articlestandard/pharmtecheurope/292009/610859null HTML http://www.ptemag.com/pharmtecheurope/Latest+News/Pharma-tackles-tropical-diseases/ArticleStandard/Article/detail/610155?contextCategoryId=45298&ref=25 Less well-known tropical diseases are receiving growing attention and research efforts from the pharmaceutical industry, according to a report from the Federation of Pharmaceutical Manufacturers & Associations (IFPMA). 2009-07-17T04:00:00Z http://www.ptemag.com/pharmtecheurope/data/articlestandard/pharmtecheurope/282009/610155null HTML http://www.ptemag.com/pharmtecheurope/Latest+News/Approximately-3-billion-boost-for-FDA/ArticleStandard/Article/detail/611221?contextCategoryId=45298&ref=25 Last week, the US House of Representatives passed H.R. 2997, the Fiscal Year 2010 Agriculture-FDA Appropriations bill, which sets aside $2.995 billion for the US Food and Drug Administration. 2009-07-17T04:00:00Z http://www.ptemag.com/pharmtecheurope/data/articlestandard/pharmtecheurope/292009/611221null HTML http://www.ptemag.com/pharmtecheurope/Latest+News/SOCMA-supports-extension-of-CFATS/ArticleStandard/Article/detail/611227?contextCategoryId=45298&ref=25 The Society of Chemical Manufacturers and Affiliates (SOCMA) this week stated its support to the US Senate for approving legislation that would extend existing chemical security standards for one more year. 2009-07-17T04:00:00Z http://www.ptemag.com/pharmtecheurope/data/articlestandard/pharmtecheurope/292009/611227null HTML http://www.ptemag.com/pharmtecheurope/Latest+News/Final-counterfeit-gang-member-sentenced/ArticleStandard/Article/detail/610979?contextCategoryId=45298&ref=25 The UK's largest counterfeit drug operation has ended in the sentencing of its seventh and final member. 2009-07-17T04:00:00Z http://www.ptemag.com/pharmtecheurope/data/articlestandard/pharmtecheurope/292009/610979null HTML http://www.ptemag.com/pharmtecheurope/Latest+News/UK-chemical-industry-under-threat/ArticleStandard/Article/detail/610858?contextCategoryId=45298&ref=25 In the wake of Dow Chemical's announcement that it is to close facilities in the UK, the country's biggest union, Unite, has called for urgent intervention from the Government to avert, what it believes, could be a crisis in the UK chemical sector. 2009-07-17T04:00:00Z http://www.ptemag.com/pharmtecheurope/data/articlestandard/pharmtecheurope/292009/610858null HTML http://www.ptemag.com/pharmtecheurope/Latest+News/New-FDA-anticounterfeiting-draft-guidance/ArticleStandard/Article/detail/611223?contextCategoryId=45298&ref=25 The FDA issued a draft guidance for industry, Incorporation of Physical-Chemical Identifiers into Solid Oral Dosage Form Drug Products for Anticounterfeiting, on July 13. 2009-07-17T04:00:00Z http://www.ptemag.com/pharmtecheurope/data/articlestandard/pharmtecheurope/292009/611223null HTML http://www.ptemag.com/pharmtecheurope/Latest+News/US-Committee-votes-on-generic-competition/ArticleStandard/Article/detail/611225?contextCategoryId=45298&ref=25 This week, the Biotechnology Industry Organization (BIO) and the Generic Pharmaceutical Association (GPhA) issued their opposing statements in reaction to the July 13 passage of an amendment from the US Senate Committee on Health, Education, Labor, and Pensions (HELP) regarding the creation of a pathway for the approval of new competitors of biologic drugs. 2009-07-17T04:00:00Z http://www.ptemag.com/pharmtecheurope/data/articlestandard/pharmtecheurope/292009/611225null HTML http://www.ptemag.com/pharmtecheurope/Latest+News/MHRA-offers-online-reporting-for-antiviral-meds/ArticleStandard/Article/detail/610156?contextCategoryId=45298&ref=25 The UK's Medicines and Healthcare Regulatory Agency (MHRA) intends to keep a close eye on the safety of the swine flu antiviral medicines Tamiflu and Relenza as their use increases, by using an online reporting system. 2009-07-17T04:00:00Z http://www.ptemag.com/pharmtecheurope/data/articlestandard/pharmtecheurope/282009/610156null HTML http://www.ptemag.com/pharmtecheurope/Latest+News/IMA-Group-acquires-PharmaSiena/ArticleStandard/Article/detail/608795?contextCategoryId=45298&ref=25 Through its subsidiary IMA Life Srl, IMA SpA has acquired 51% of PharmaSiena Srl, which designs and produces filling machines for ampoules and syringes in aseptic environments. 2009-07-16T04:00:00Z http://www.ptemag.com/pharmtecheurope/data/articlestandard/pharmtecheurope/282009/608795null HTML http://www.ptemag.com/pharmtecheurope/Latest+News/Spain-constructs-first-vaccine-plant/ArticleStandard/Article/detail/608793?contextCategoryId=45298&ref=25 Spain's first in-border facility to develop pandemic and seasonal influenza vaccines will be built under a 60 million euro programme sponsored and led by the Spanish Ministry of Health. 2009-07-10T04:00:00Z http://www.ptemag.com/pharmtecheurope/data/articlestandard/pharmtecheurope/282009/608793null HTML http://www.ptemag.com/pharmtecheurope/Latest+News/EC-final-report-condemns-industry-malpractice/ArticleStandard/Article/detail/609486?contextCategoryId=45298&ref=25 The European Commission has confirmed that the market entry of generic drugs is delayed and that company practices are among the causes in its final report on the competition inquiry into the pharmaceutical sector. 2009-07-10T04:00:00Z http://www.ptemag.com/pharmtecheurope/data/articlestandard/pharmtecheurope/282009/609486null HTML http://www.ptemag.com/pharmtecheurope/Latest+News/Pharmerging-markets-and-the-new-world-order/ArticleStandard/Article/detail/607499?contextCategoryId=45298&ref=25 An IMS press briefing earlier this month dramatically predicted a new world ranking of global pharma markets by 2013. But there's more to just knowing where these markets are in order to succeed in the 'new world order.' 2009-07-10T04:00:00Z http://www.ptemag.com/pharmtecheurope/data/articlestandard/pharmtecheurope/272009/607499null HTML http://www.ptemag.com/pharmtecheurope/Latest+News/Once-daily-diabetes-treatment-gets-EU-OK/ArticleStandard/Article/detail/608790?contextCategoryId=45298&ref=25 The European Commission has granted marketing authorization for Novo Nordisk's Victoza (liraglutide). 2009-07-10T04:00:00Z http://www.ptemag.com/pharmtecheurope/data/articlestandard/pharmtecheurope/282009/608790null HTML http://www.ptemag.com/pharmtecheurope/Latest+News/Roche-waves-goodbye-to-pharma/ArticleStandard/Article/detail/608792?contextCategoryId=45298&ref=25 Roche appears to want out of the Big Pharma crowd. A report from the UK's Financial Times claims that Roche will not renew its membership of the Association of the British Pharmaceutical Industry (ABPI), while the company has also confirmed that it has officially withdrawn from the US's Pharmaceutical Research and Manufacturers Association (PhRMA). 2009-07-10T04:00:00Z http://www.ptemag.com/pharmtecheurope/data/articlestandard/pharmtecheurope/282009/608792null HTML http://www.ptemag.com/pharmtecheurope/Latest+News/Fake-Tamiflu-warning/ArticleStandard/Article/detail/608791?contextCategoryId=45298&ref=25 With the World Health Organization (WHO) having declared the spread of swine flu "unstoppable" at a recent meeting in Mexico, there is increasing concern about counterfeits of Roche's anti-viral medicine Tamiflu, which are being purchased over the internet by panicking consumers. 2009-07-10T04:00:00Z http://www.ptemag.com/pharmtecheurope/data/articlestandard/pharmtecheurope/282009/608791null HTML http://www.ptemag.com/pharmtecheurope/Latest+News/JampJ-invests-15-billion-in-deal-with-Elan/ArticleStandard/Article/detail/609396?contextCategoryId=45298&ref=25 ohnson & Johnson (J&J, NJ, USA) has agreed to pay $1 billion (719 million euro) to acquire the assets and rights of the Alzheimer’s immunotherapy programme (AIP) of the biopharmaceutical company Elan (Ireland), to form a new company with Elan based on the AIP programme, and gain an 18.4% stake in Elan. 2009-07-09T04:00:00Z http://www.ptemag.com/pharmtecheurope/data/articlestandard/pharmtecheurope/282009/609396null HTML http://www.ptemag.com/pharmtecheurope/Latest+News/USP-seeks-comments-on-four-excipient-monographs/ArticleStandard/Article/detail/609395?contextCategoryId=45298&ref=25 The US Pharmacopeia is revising its monographs for four pharmaceutical excipients: propylene glycol, sorbitol solution, sorbitol sorbitan solution, and noncrystalllizing sorbitol solution. 2009-07-09T04:00:00Z http://www.ptemag.com/pharmtecheurope/data/articlestandard/pharmtecheurope/282009/609395null HTML http://www.ptemag.com/pharmtecheurope/Latest+News/Final-stem-cell-research-rules-issued/ArticleStandard/Article/detail/609397?contextCategoryId=45298&ref=25 The US National Institutes of Health (NIH) have issued on 7 July final guidelines for human stem-cell research that widen the door to the cell lines that can be used if they meet certain ethical requirements. 2009-07-09T04:00:00Z http://www.ptemag.com/pharmtecheurope/data/articlestandard/pharmtecheurope/282009/609397null HTML http://www.ptemag.com/pharmtecheurope/Latest+News/Two-patents-for-PolyTherics-in-record-time/ArticleStandard/Article/detail/609394?contextCategoryId=45298&ref=25 Only two weeks after being granted a European patent covering the targeted PEGylation of proteins, PolyTherics has been granted a patent for the same technology — TheraPEG — in the US. 2009-07-08T04:00:00Z http://www.ptemag.com/pharmtecheurope/data/articlestandard/pharmtecheurope/282009/609394null HTML http://www.ptemag.com/pharmtecheurope/Latest+News/Rheumatoid-arthritis-treatment-gets-EU-thumbs-up/ArticleStandard/Article/detail/607310?contextCategoryId=45298&ref=25 The Committee for Medicinal Products for Human Use (CHMP) of the EMEA has recommended that the EC grants a marketing authorization for Belgium based-UCB's Cimzia, in combination with methotrexate, for the treatment of rheumatoid arthritis (RA). 2009-07-03T04:00:00Z http://www.ptemag.com/pharmtecheurope/data/articlestandard/pharmtecheurope/272009/607310null HTML http://www.ptemag.com/pharmtecheurope/Latest+News/New-EU-committee-leaves-member-states-out-in-the-c/ArticleStandard/Article/detail/607306?contextCategoryId=45298&ref=25 Although all Member States are in favouring of tightening pharmacovigilance rules, which element of the 'pharma package' is causing dispute? 2009-07-03T04:00:00Z http://www.ptemag.com/pharmtecheurope/data/articlestandard/pharmtecheurope/272009/607306null HTML http://www.ptemag.com/pharmtecheurope/Latest+News/UK-strengthens-medicines-supply-chain/ArticleStandard/Article/detail/607307?contextCategoryId=45298&ref=25 The UK's Medicines and Healthcare Regulatory Agency (MHRA) has published the outcome of a consultation on measures to strengthen the country's medicines supply chain. 2009-07-03T04:00:00Z http://www.ptemag.com/pharmtecheurope/data/articlestandard/pharmtecheurope/272009/607307null HTML http://www.ptemag.com/pharmtecheurope/Latest+News/Artificial-liver-aids-drug-testing/ArticleStandard/Article/detail/607308?contextCategoryId=45298&ref=25 Could artificial organs help replace animals experiments? Researchers at the Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB (Germany) believe so; they have developed an artificial liver that they believe will offer greater security for pharma companies and shorten the path to new drugs. 2009-07-03T04:00:00Z http://www.ptemag.com/pharmtecheurope/data/articlestandard/pharmtecheurope/272009/607308null HTML http://www.ptemag.com/pharmtecheurope/Latest+News/FTC-issues-report-on-authorized-generics/ArticleStandard/Article/detail/607844?contextCategoryId=45298&ref=25 The Federal Trade Commission (FTC) last week issued an interim report that examined the effects of authorized generics on competition in the prescription drug market. 2009-07-03T04:00:00Z http://www.ptemag.com/pharmtecheurope/data/articlestandard/pharmtecheurope/272009/607844null HTML http://www.ptemag.com/pharmtecheurope/Latest+News/European-Knowledge-Centre-opened-in-the-UK/ArticleStandard/Article/detail/607309?contextCategoryId=45298&ref=25 Eisai (Japan) has opened its new European Knowledge Centre in Hertfordshire (UK) after investing approximately 117 million euro in the region to help develop new medicines for Alzheimer's Disease, Parkinson's Disease and epilepsy, as well as new treatments for cancer. 2009-07-03T04:00:00Z http://www.ptemag.com/pharmtecheurope/data/articlestandard/pharmtecheurope/272009/607309null HTML http://www.ptemag.com/pharmtecheurope/Latest+News/USP-collaborates-with-Asian-authorities/ArticleStandard/Article/detail/607843?contextCategoryId=45298&ref=25 The US Pharmacopeial (USP) Convention and the Vietnamese Pharmacopoeia Commission (VPC) have signed a memorandum of understanding (MOU) that will help ensure the safety of Vietnamese medicines. 2009-07-02T04:00:00Z http://www.ptemag.com/pharmtecheurope/data/articlestandard/pharmtecheurope/272009/607843null HTML http://www.ptemag.com/pharmtecheurope/Latest+News/Improving-asthma-treatments/ArticleStandard/Article/detail/608490?contextCategoryId=45298&ref=25 Better asthma treatments are hoped to arise from a collaboration between Domainex Ltd, St George?s University of London and the University of Manchester (all UK). 2009-07-02T04:00:00Z http://www.ptemag.com/pharmtecheurope/data/articlestandard/pharmtecheurope/272009/608490null HTML http://www.ptemag.com/pharmtecheurope/Latest+News/FDA-inspects-Hoviones-API-manufacturing-plant/ArticleStandard/Article/detail/607860?contextCategoryId=45298&ref=25 Hovione's API plant in Macau (CA, USA), which is responsible for one third of the company's total production, has successfully passed a pre-approval inspection by the FDA. 2009-07-01T04:00:00Z http://www.ptemag.com/pharmtecheurope/data/articlestandard/pharmtecheurope/272009/607860null HTML http://www.ptemag.com/pharmtecheurope/Latest+News/US-Marshalls-seize-Caracos-drug-products/ArticleStandard/Article/detail/607842?contextCategoryId=45298&ref=25 On 25 June, US Marshalls seized all drug products and ingredients at three facilities of Caraco Pharmaceutical Laboratories: Detroit, Farmington Hills and Wixom (MI, USA) Michigan. 2009-07-01T04:00:00Z http://www.ptemag.com/pharmtecheurope/data/articlestandard/pharmtecheurope/272009/607842null HTML http://www.ptemag.com/pharmtecheurope/Latest+News/Will-biotech-rule-pharmas-world-in-2014/ArticleStandard/Article/detail/605709?contextCategoryId=45298&ref=25 According to market analysis firm EvaluatePharma, the top six selling drugs of 2014 are all expected to be biotech products compared with only five in 2008 and one in 2000. 2009-06-26T04:00:00Z http://www.ptemag.com/pharmtecheurope/data/articlestandard/pharmtecheurope/262009/605709null HTML http://www.ptemag.com/pharmtecheurope/Latest+News/FDA-approves-first-macular-oedema-drug-therapy/ArticleStandard/Article/detail/605708?contextCategoryId=45298&ref=25 The FDA has approved the first drug therapy for the treatment of macular oedema following branch retinal vein occlusion or central retinal vein occlusion, which is a significant cause of vision loss. 2009-06-26T04:00:00Z http://www.ptemag.com/pharmtecheurope/data/articlestandard/pharmtecheurope/262009/605708null HTML http://www.ptemag.com/pharmtecheurope/Latest+News/Big-Pharma-to-donate-swine-flu-vaccines/ArticleStandard/Article/detail/605714?contextCategoryId=45298&ref=25 Sanofi-aventis will donate 100 million doses of vaccine against the pandemic H1N1 2009 virus to the World Health Organization (WHO). 2009-06-26T04:00:00Z http://www.ptemag.com/pharmtecheurope/data/articlestandard/pharmtecheurope/262009/605714null HTML http://www.ptemag.com/pharmtecheurope/Latest+News/Vetter-claims-success-with-new-facility/ArticleStandard/Article/detail/605713?contextCategoryId=45298&ref=25 Vetter has completed the installation of six automatic packaging lines at its new packaging services facility in Ravensburg (Germany). 2009-06-24T04:00:00Z http://www.ptemag.com/pharmtecheurope/data/articlestandard/pharmtecheurope/262009/605713null HTML http://www.ptemag.com/pharmtecheurope/Latest+News/PEGylated-patent-for-PolyTherics/ArticleStandard/Article/detail/605744?contextCategoryId=45298&ref=25 PolyTherics's first patent covering the targeted PEGylation of proteins has been allowed in Europe. 2009-06-23T04:00:00Z http://www.ptemag.com/pharmtecheurope/data/articlestandard/pharmtecheurope/262009/605744null HTML http://www.ptemag.com/pharmtecheurope/Latest+News/Budenheim-achieves-GMP-certification/ArticleStandard/Article/detail/605607?contextCategoryId=45298&ref=25 Budenheim, a producer of pharmaceutical grade Phosphate, is now formally certified according to the ?Good Manufacturing Practice Guidelines for Active Pharmaceutical Ingredients? (ICH Q7A). 2009-06-23T04:00:00Z http://www.ptemag.com/pharmtecheurope/data/articlestandard/pharmtecheurope/262009/605607null HTML http://www.ptemag.com/pharmtecheurope/Latest+News/EMEA-launches-public-consultation-on-new-transpare/ArticleStandard/Article/detail/605609?contextCategoryId=45298&ref=25 The European Medicines Agency (EMEA) is inviting comments on its draft transparency policy. 2009-06-23T04:00:00Z http://www.ptemag.com/pharmtecheurope/data/articlestandard/pharmtecheurope/262009/605609null HTML http://www.ptemag.com/pharmtecheurope/Latest+News/EFCG-launches-new-guidelines-compliance-tool/ArticleStandard/Article/detail/605605?contextCategoryId=45298&ref=25 Following the 2008 launch of the European Fine Chemicals Group (EFCG) Voluntary Guidelines (VGs) to promote supply chain security, the group has now announced the official launch of an assessment template that will allow fine chemicals customers and suppliers to assess and implement this new set of recommendations. 2009-06-23T04:00:00Z http://www.ptemag.com/pharmtecheurope/data/articlestandard/pharmtecheurope/262009/605605null HTML http://www.ptemag.com/pharmtecheurope/Latest+News/Swine-flu-vaccine-manufacture-underway/ArticleStandard/Article/detail/604912?contextCategoryId=45298&ref=25 Protein Sciences Corp (CT, USA) is the latest company to join the H1N1 influenza vaccine race after initiating manufacture of its vaccine PanBlok, which is made using the company's baculovirus and insect cell manufacturing technology. 2009-06-19T04:00:00Z http://www.ptemag.com/pharmtecheurope/data/articlestandard/pharmtecheurope/252009/604912null HTML http://www.ptemag.com/pharmtecheurope/Latest+News/Report-on-follow-on-biologics-sparks-debate/ArticleStandard/Article/detail/604636?contextCategoryId=45298&ref=25 The Subcommittee on Health of the US House of Representatives Energy and Commerce Committee held hearings last week to discuss the findings of a report by the Federal Trade Commission (FTC) that examined the competitive effects for follow-on-biologics (FOBs). 2009-06-19T04:00:00Z http://www.ptemag.com/pharmtecheurope/data/articlestandard/pharmtecheurope/252009/604636null HTML http://www.ptemag.com/pharmtecheurope/Latest+News/Renvela-approved-for-chronic-kidney-disease/ArticleStandard/Article/detail/603812?contextCategoryId=45298&ref=25 The European Commission has approved Genzyme Corp's Renvela for patients with chronic kidney disease (CKD). The approval covers both tablet and powder formulations. 2009-06-18T04:00:00Z http://www.ptemag.com/pharmtecheurope/data/articlestandard/pharmtecheurope/252009/603812null HTML http://www.ptemag.com/pharmtecheurope/Latest+News/Controversial-EU-cross-border-directive/ArticleStandard/Article/detail/603813?contextCategoryId=45298&ref=25 Draft legislation that would allow patients to seek treatment in any EU country was attacked at the annual congress of the European Federation of Public Services Union (EPSU), which urged European Union health ministers to redraft the proposal so that its legal basis encompasses public health and not just the internal market. 2009-06-18T04:00:00Z http://www.ptemag.com/pharmtecheurope/data/articlestandard/pharmtecheurope/252009/603813null HTML http://www.ptemag.com/pharmtecheurope/Latest+News/Eli-Lilly-faces-lawsuits-for-illegal-marketing/ArticleStandard/Article/detail/603815?contextCategoryId=45298&ref=25 Eli Lilly urged doctors to prescribe Zyprexa for elderly dementia patients despite having evidence that the medicine was not effective for those patients, says a report by Bloomberg. 2009-06-18T04:00:00Z http://www.ptemag.com/pharmtecheurope/data/articlestandard/pharmtecheurope/252009/603815null HTML http://www.ptemag.com/pharmtecheurope/Latest+News/Europe-takes-action-on-rare-diseases/ArticleStandard/Article/detail/603814?contextCategoryId=45298&ref=25 Stakeholders say that Europe and its rare disease patients will benefit from a series of political commitments that Health Ministers from all 27 member states have signed up to by adopting a Council Recommendation on European Action in the Field of Rare Diseases. 2009-06-18T04:00:00Z http://www.ptemag.com/pharmtecheurope/data/articlestandard/pharmtecheurope/252009/603814null HTML http://www.ptemag.com/pharmtecheurope/Latest+News/Industry-and-health-agencies-respond-to-influenza-/ArticleStandard/Article/detail/604225?contextCategoryId=45298&ref=25 Following the World Health Organization?s (WHO) declaration last week of an influenza pandemic, vaccine makers in Europe and China as well as world health agencies are stepping up efforts toward rapid development and approval of an effective vaccine. 2009-06-17T04:00:00Z http://www.ptemag.com/pharmtecheurope/data/articlestandard/pharmtecheurope/252009/604225null HTML http://www.ptemag.com/pharmtecheurope/Latest+News/EMEA-seeks-your-opinion/ArticleStandard/Article/detail/603811?contextCategoryId=45298&ref=25 Following changes to European legislation, the European Medicines Agency (EMEA) will make public some of the information in EudraCT — a database that contains information on clinical trials in Europe. 2009-06-16T04:00:00Z http://www.ptemag.com/pharmtecheurope/data/articlestandard/pharmtecheurope/252009/603811null HTML http://www.ptemag.com/pharmtecheurope/Latest+News/European-Commission-wont-pursue-directive-for-exci/ArticleStandard/Article/detail/602773?contextCategoryId=45298&ref=25 The European Commission?s (EC) Directorate-General for Enterprise and Industry (EC–DG Enterprise) announced last week that it will not continue preparing a commission directive on good manufacturing practices (GMPs) for certain excipients. 2009-06-12T04:00:00Z http://www.ptemag.com/pharmtecheurope/data/articlestandard/pharmtecheurope/242009/602773null HTML http://www.ptemag.com/pharmtecheurope/Latest+News/MHRA-seeks-improved-legislative-framework/ArticleStandard/Article/detail/602772?contextCategoryId=45298&ref=25 The outcome of a concept paper by the UK's Medicines and Healthcare products Regulatory Agency (MHRA), which sought the input of stakeholders on the review and consolidation of the UK medicines legislation, has been published. 2009-06-12T04:00:00Z http://www.ptemag.com/pharmtecheurope/data/articlestandard/pharmtecheurope/242009/602772null HTML http://www.ptemag.com/pharmtecheurope/Latest+News/New-centre-for-research-opens-in-UK/ArticleStandard/Article/detail/602646?contextCategoryId=45298&ref=25 A new Faculty of Translational Medicine has been established in London (UK) that will increase support for, and enhance collaboration among, researchers as they search for new treatments and diagnostic tests for a range of diseases and conditions. 2009-06-12T04:00:00Z http://www.ptemag.com/pharmtecheurope/data/articlestandard/pharmtecheurope/242009/602646null HTML http://www.ptemag.com/pharmtecheurope/Latest+News/Biologic-manufacturing-facility-to-be-built-in-Ind/ArticleStandard/Article/detail/602774?contextCategoryId=45298&ref=25 India-based Kemwell plans to build a new biopharmaceutical manufacturing plant in Bangalore (India) in a strategic collaboration with Boehringer Ingelheim (BI, Germany). 2009-06-12T04:00:00Z http://www.ptemag.com/pharmtecheurope/data/articlestandard/pharmtecheurope/242009/602774null HTML http://www.ptemag.com/pharmtecheurope/Latest+News/Europe-needs-faster-generic-medicines-uptake/ArticleStandard/Article/detail/602771?contextCategoryId=45298&ref=25 "EU governments need to ensure fast generic medicines uptake as market access and low market volume in key EU countries is still a real problem and is having a major negative impact on patient access to more affordable treatments." 2009-06-12T04:00:00Z http://www.ptemag.com/pharmtecheurope/data/articlestandard/pharmtecheurope/242009/602771null HTML http://www.ptemag.com/pharmtecheurope/Latest+News/EU-wide-recall-of-Raptiva/ArticleStandard/Article/detail/602648?contextCategoryId=45298&ref=25 The European Medicines Agency (EMEA) has agreed to an EU-wide recall of all the remaining batches of Merck Serono's Raptiva because of the risk of a serious brain infection. Following the recall, the medicine will no longer be available anywhere in the European Union. 2009-06-12T04:00:00Z http://www.ptemag.com/pharmtecheurope/data/articlestandard/pharmtecheurope/242009/602648null HTML http://www.ptemag.com/pharmtecheurope/Latest+News/JampJ-fights-for-Remicade-rights/ArticleStandard/Article/detail/601192?contextCategoryId=45298&ref=25 Johnson & Johnson is making a break for escape with global sales of the rheumatoid arthritis treatment Remicade, which the company currently shares with Schering-Plough via a distribution agreement. 2009-06-05T04:00:00Z http://www.ptemag.com/pharmtecheurope/data/articlestandard/pharmtecheurope/232009/601192null HTML http://www.ptemag.com/pharmtecheurope/Latest+News/Atherosclerosis-vaccine-receives-EU-funding/ArticleStandard/Article/detail/601191?contextCategoryId=45298&ref=25 Austria-based AFFiRiS AG is receiving financial support worth several hundred thousand euro for its atherosclerosis vaccine development programme from the European Union's call. 2009-06-05T04:00:00Z http://www.ptemag.com/pharmtecheurope/data/articlestandard/pharmtecheurope/232009/601191null HTML http://www.ptemag.com/pharmtecheurope/Latest+News/Marketing-authorization-withdrawn-for-Biferonex/ArticleStandard/Article/detail/601201?contextCategoryId=45298&ref=25 BioPartners GmbH (Switzerland) has formally notified the European Medicines Agency (EMEA) of its decision to withdraw the application of a centralized marketing authorization for Biferonex (interferon beta 1a), 6 million-international-unit solution for injection, prefilled syringes for subcutaneous administration. 2009-06-05T04:00:00Z http://www.ptemag.com/pharmtecheurope/data/articlestandard/pharmtecheurope/232009/601201null HTML http://www.ptemag.com/pharmtecheurope/Latest+News/RAPS-enters-Europe/ArticleStandard/Article/detail/601204?contextCategoryId=45298&ref=25 The Regulatory Affairs Professionals Society (RAPS) — the world's largest international membership organization of regulatory professionals in the medical device, pharmaceutical and biotechnology sectors — has opened a European office in Brussels (Belgium) that will support programmes, events and operations across Europe, as well as serve as the region's headquarters. 2009-06-05T04:00:00Z http://www.ptemag.com/pharmtecheurope/data/articlestandard/pharmtecheurope/232009/601204null HTML http://www.ptemag.com/pharmtecheurope/Latest+News/EU-DTC-rules-to-change/ArticleStandard/Article/detail/601202?contextCategoryId=45298&ref=25 The UK's Medicines and Healthcare products Regulatory Agency (MHRA) is seeking opinions on a European Commission (EC) proposal that would allow drugmakers to disseminate certain information on prescription medicines directly to European patients. 2009-06-05T04:00:00Z http://www.ptemag.com/pharmtecheurope/data/articlestandard/pharmtecheurope/232009/601202null HTML http://www.ptemag.com/pharmtecheurope/Latest+News/AstraZeneca-amp-Merck-in-unique-deal/ArticleStandard/Article/detail/601199?contextCategoryId=45298&ref=25 In a novel collaboration, pharma giants AstraZeneca and Merck will investigate the potential benefits of combining their two early-stage compounds for the treatment of solid cancer tumours. 2009-06-05T04:00:00Z http://www.ptemag.com/pharmtecheurope/data/articlestandard/pharmtecheurope/232009/601199null HTML http://www.ptemag.com/pharmtecheurope/Latest+News/Brand-makers-abusing-authorized-generics/ArticleStandard/Article/detail/601819?contextCategoryId=45298&ref=25 The Chief Operating Officer (COO) of one of the world?s largest generics manufacturers has condemned the launch of authorized generics during 180-day exclusivity periods. 2009-06-05T04:00:00Z http://www.ptemag.com/pharmtecheurope/data/articlestandard/pharmtecheurope/232009/601819null HTML http://www.ptemag.com/pharmtecheurope/Latest+News/US-issues-new-drug-safety-guidelines/ArticleStandard/Article/detail/601377?contextCategoryId=45298&ref=25 A discussion draft of the Food Safety Enhancement Act of 2009 has been released, which also contains measures relating to drug safety. 2009-06-05T04:00:00Z http://www.ptemag.com/pharmtecheurope/data/articlestandard/pharmtecheurope/232009/601377null HTML http://www.ptemag.com/pharmtecheurope/Latest+News/Genetic-link-to-drug-induced-liver-injury-found/ArticleStandard/Article/detail/601219?contextCategoryId=45298&ref=25 The International Serious Adverse Event Consortium (SAEC), a nonprofit partnership, has helped the FDA gain significant understanding of the genetic basis for drug-induced liver injury (DILI). 2009-06-05T04:00:00Z http://www.ptemag.com/pharmtecheurope/data/articlestandard/pharmtecheurope/232009/601219null HTML http://www.ptemag.com/pharmtecheurope/Latest+News/The-boom-in-the-Middle-East/ArticleStandard/Article/detail/598916?contextCategoryId=45298&ref=25 Until recently, the Middle East has accounted for only a fraction of global pharmaceutical sales, but this will soon change as the region's pharmaceutical market is estimated to exceed $18 billion by 2014. 2009-06-01T04:00:00Z http://www.ptemag.com/pharmtecheurope/data/articlestandard/pharmtecheurope/212009/598916null HTML http://www.ptemag.com/pharmtecheurope/News/News/ArticleStandard/Article/detail/600233?contextCategoryId=45298&ref=25 The latest growth forecast for the 2009 pharmaceutical market might have come as a shock to many, but there is still hope for the industry in the form of new product launches and potential blockbusters. 2009-06-01T04:00:00Z http://www.ptemag.com/pharmtecheurope/data/articlestandard/pharmtecheurope/222009/600233null XML http://www.ptemag.com/pharmtecheurope/Latest+News/European-initiative-supports-faster-development-of/ArticleStandard/Article/detail/599868?contextCategoryId=45298&ref=25 Out of 150 applications, 15 research projects aimed at bringing innovative medicines to market faster have been selected to receive 246 million euro from the European Commission (EC) and the European Federation of Pharmaceutical Industries and Associations (EFPIA). 2009-05-29T04:00:00Z http://www.ptemag.com/pharmtecheurope/data/articlestandard/pharmtecheurope/222009/599868null HTML http://www.ptemag.com/pharmtecheurope/Latest+News/Twice-as-many-therapeutic-peptides-in-the-clinic/ArticleStandard/Article/detail/599867?contextCategoryId=45298&ref=25 Thanks to advances in synthesis, delivery and formulation, the number of therapeutic peptides entering clinical trials this decade is almost double the rate of the 1990s, and investment in new therapeutic peptide product development is expected to continue at a strong pace for the foreseeable future. 2009-05-29T04:00:00Z http://www.ptemag.com/pharmtecheurope/data/articlestandard/pharmtecheurope/222009/599867null HTML http://www.ptemag.com/pharmtecheurope/Latest+News/Xention-strengthens-team/ArticleStandard/Article/detail/599869?contextCategoryId=45298&ref=25 UK-based biopharmaceutical firm Xention has strengthened its team with the appointment of Dr Calum Graham as Director of Business Development. 2009-05-29T04:00:00Z http://www.ptemag.com/pharmtecheurope/data/articlestandard/pharmtecheurope/222009/599869null HTML http://www.ptemag.com/pharmtecheurope/Latest+News/EU-amp-US-approval-process-integration-a-necessity/ArticleStandard/Article/detail/599856?contextCategoryId=45298&ref=25 There is a pressing need to integrate the regulatory environments of the EU and the US, according to new analysis by Frost & Sullivan, which believes the diverse approval processes across different continents are negatively impacting drug launches. 2009-05-29T04:00:00Z http://www.ptemag.com/pharmtecheurope/data/articlestandard/pharmtecheurope/222009/599856null HTML http://www.ptemag.com/pharmtecheurope/Latest+News/Novartis-gets-exclusive-option-to-acquire-Elixir-P/ArticleStandard/Article/detail/600034?contextCategoryId=45298&ref=25 Novartis (Switzerland) has signed an agreement that grants the company an exclusive option to acquire Elixir Pharmaceuticals (MA, USA) upon successful completion of a Phase IIa clinical study of Elixir?s lead oral ghrelin antagonist, which is now the subject of preclinical studies. 2009-05-29T04:00:00Z http://www.ptemag.com/pharmtecheurope/data/articlestandard/pharmtecheurope/222009/600034null HTML http://www.ptemag.com/pharmtecheurope/Latest+News/US-orders-H1N1-vaccines-and-vaccine-antigen/ArticleStandard/Article/detail/600031?contextCategoryId=45298&ref=25 The US Department of Health and Human Services (HHS) this week placed an initial order with Sanofi Pasteur (France) for a vaccine to fight influenza A (H1N1) infection. 2009-05-29T04:00:00Z http://www.ptemag.com/pharmtecheurope/data/articlestandard/pharmtecheurope/222009/600031null HTML http://www.ptemag.com/pharmtecheurope/Latest+News/Whos-the-best-in-global-biotech/ArticleStandard/Article/detail/599862?contextCategoryId=45298&ref=25 A study has identified the innovative strength of more than 30 countries when it comes to biotechnology. Who came out on top? 2009-05-29T04:00:00Z http://www.ptemag.com/pharmtecheurope/data/articlestandard/pharmtecheurope/222009/599862null HTML http://www.ptemag.com/pharmtecheurope/APIs/Next-generation-of-API-purification-technologies/ArticleStandard/Article/detail/599864?contextCategoryId=45298&ref=25 A consortium with a specific focus on removing organic impurities from API production has been selected by the European Commission (EC) to receive funding of approximately 3 million euro. 2009-05-29T04:00:00Z http://www.ptemag.com/pharmtecheurope/data/articlestandard/pharmtecheurope/222009/599864null HTML